| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $164.6M | -40.2% |
| R&D Expense | $199.6M | +3.7% |
| SG&A Expense | $47.5M | +22.3% |
| Operating Income | -$82.5M | -288.4% |
| Pre-tax Income | -$54.5M | -166.0% |
| Income Tax | $673K | — |
| Net Income | -$55.2M | -166.8% |
| EPS (Basic) | -$0.93 | -165.5% |
| EPS (Diluted) | -$0.93 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.9M | -62.4% |
| Accounts Receivable | $29.0M | -56.3% |
| Current Assets | $675.3M | +59.1% |
| Total Assets | $846.3M | +1.0% |
| Current Liabilities | $63.8M | -9.7% |
| Total Liabilities | $118.8M | +13.4% |
| Stockholders' Equity | $727.5M | -0.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.5M | +245.3% |
| Capital Expenditures | $38.5M | +189.5% |
| Investing Cash Flow | -$119.7M | -158.9% |
| Financing Cash Flow | $5.7M | -86.8% |
| Free Cash Flow | -$14.0M | +53.5% |
| -167.9% |